Categories

Actinic Keratosis-Pipeline Insights, 2015

US$ 1250

Actinic Keratosis- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Actinic Keratosis. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals.

05-14 2015   Pages: 60

Acne Vulgaris-Pipeline Insights, 2015

US$ 1250

“Table of Contents •  Acne Vulgaris Overview •  Acne Vulgaris Pipeline Therapeutics •  Acne Vulgaris Therapeutics under Development by Companies  •  Acne Vulgaris Late S …

05-14 2015   Pages: 60

Acinetobacter Infections-Pipeline Insights, 2015

US$ 1250

Acinetobacter Infections- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Acinetobacter Infections.

05-14 2015   Pages: 60

Abscess-Pipeline Insights, 2015

US$ 1250

Abscess- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Abscess. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals.

05-14 2015   Pages: 60

Abdominal Obesity-Pipeline Insights, 2015

US$ 1250

Abdominal Obesity- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Abdominal Obesity. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals.

05-14 2015   Pages: 60

Humatrope – Drug Insights, 2015

US$ 1000

The report covers the Global Market Assessment of the “Humatrope covering the total sales estimation for the countries in which the drug is approved and also provides the Humatropesales performance during the forecast period (2012-2016).

05-06 2015   Pages: NO

Seroxat – Drug Insights, 2015

US$ 1000

The report covers the Global Market Assessment of the “Seroxat covering the total sales estimation for the countries in which the drug is approved and also provides the Seroxatsales performance during the forecast period (2012-2016).

05-06 2015   Pages: NO

Gynorest – Drug Insights, 2015

US$ 1000

The report covers the Global Market Assessment of the “Gynorest covering the total sales estimation for the countries in which the drug is approved and also provides the Gynorestsales performance during the forecast period (2012-2016).

05-06 2015   Pages: NO

Ranexa – Drug Insights, 2015

US$ 1000

DelveInsight’s pharmaceuticals report, “Ranexa- Drug Insights, 2015” highlights the Ranexa marketed details and the Global API Manufacturers details across the globe along with the location.

05-06 2015   Pages: NO
Contact With Us
Join templatemonster at google+
Customized Research
Request Sample